ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1418	National Cancer Institute	Html	en	Cancer-Related Post-traumatic Stress (PDQ®)–Patient Version	Shock, fear, helplessness, or horror can be felt by cancer patients at any time and lead to cancer-related post-traumatic stress. Learn about the causes and ways doctors can help manage these symptoms of distress in this expert-reviewed summary.	cancer treatment 0.338437 life-threatening stress 0.303648 natural disasters 0.295492 PDQ cancer information 0.517368 upsetting event 0.305231 clinical trial search 0.288109 certain triggers 0.298605 stressful events 0.297941 clinical trials 0.416557 cancer information summary 0.420357 clinical trial 0.342943 breast cancer prevention 0.304611 PDQ summaries 0.31577 patients 0.413744 cancer patients 0.39239 latest published information 0.297252 childhood cancer survivors 0.334732 cancer-related PTS 0.301933 NCI’s PDQ 0.315928 NCI PDQ cancer 0.384736 cancer survivors 0.382895 violent personal attack 0.28851 cancer-related post-traumatic stress 0.771546 Breast cancer survivors 0.324986	treatment 0.388516 post-traumatic stress disorder 0.44428 cancer prevention 0.308777 cancer experience 0.306174 anxiety disorders 0.288817 Cancer Information Service 0.325795 PDQ Supportive 0.310148 treatment clinical trials 0.303343 National Cancer Institute 0.448327 post-traumatic stress symptoms 0.498161 PDQ documents 0.307297 early symptoms 0.28734 Palliative Care Editorial 0.346292 new treatment 0.299459 possible cancer recurrence 0.324764 PDQ database 0.313308 Cancer Care page 0.31311 Care Editorial Board 0.347322 PDQ summary 0.393635 PTSD 0.349898 PTSD). 0.290236 cancer clinical trials 0.330243 cancer information summaries 0.334057 comprehensive cancer information 0.334182	CLICK HERE
1491	National Cancer Institute	Html	en	Laryngeal Cancer Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of laryngeal cancer.	Elective neck radiation 0.612858 locally advanced head 0.629434 radiation therapy-based treatment 0.65069 randomized controlled trials 0.580539 Engl J Med 0.592068 advanced laryngeal cancer 0.614525 radiation therapy. 0.583072 Laryngeal Cancer Study 0.614831 laryngeal cancer 0.719655 Int J Radiat 0.605237 randomized study 0.574463 Radiation Therapy Oncology 0.613999 neck cancer patients 0.594571 Radiat Oncol Biol 0.689017 induction chemotherapy group 0.591432 patients 0.718736 initial radiation 0.58218 standard treatment options 0.574341 lymph nodes 0.592104 early-stage larynx cancer 0.642059 radiation therapy 0.991511 beam radiation therapy 0.610314 et al. 0.672465 concomitant chemotherapy 0.657903	larynx cancer 0.643614 Affairs Laryngeal Cancer 0.575648 radiation failures 0.582504 altered fractionation radiation 0.602814 intensity-modulated radiation therapy 0.607841 laryngeal cancers 0.598434 Concurrent radiation therapy 0.626365 advanced larynx cancer 0.579933 radiation field 0.584791 high local control 0.57619 definitive radiation therapy 0.62584 local control 0.651065 external-beam radiation therapy 0.622106 early-stage laryngeal cancer 0.582781 Oncol Biol Phys 0.693462 lymph node involvement 0.5855 particle-beam radiation therapy 0.628769 neck cancer 0.66828 lymph node 0.614894 treatment options 0.588529 local progression-free survival 0.574463 induction chemotherapy 0.734401 Cancer Study Group 0.595423 squamous cell carcinoma 0.619401	CLICK HERE
1755	National Cancer Institute	Html	en	Genetic Testing for Hereditary Cancer Syndromes	A fact sheet about genetic testing for inherited cancer risk. Includes types of tests, who should consider testing, and how to understand test results.	negative test result 0.400337 health care provider 0.502328 genetic mutation 0.416497 family member 0.418619 harmful genetic mutation 0.411753 cancer-predisposing mutation 0.409751 hereditary cancer disorders 0.398762 hereditary cancer syndromes 0.681889 cancer risk condition 0.40678 health care providers 0.394471 hereditary cancer syndrome 0.621674 family members 0.522464 test results 0.569131 major hereditary cancer 0.393709 possible cancer risk 0.406537 certain hereditary cancer 0.433421 cancer types 0.481189 DTC genetic tests 0.42978 person 0.492341 Genetic Information Nondiscrimination 0.390123 genetic tests 0.554486 specific genetic change 0.3911 specific cancer type 0.391368 genetic counselor 0.453074 male breast cancer 0.389105	DTC genetic testing 0.513411 genetic counseling 0.415519 disease-related genetic mutation 0.41195 family medical history 0.39883 positive test result 0.403147 common inherited cancer 0.408932 particular genetic test 0.407943 inherited genetic variants 0.392436 genetic information 0.399804 health care 0.626411 genetic test results 0.557316 genetic change 0.403267 at-home genetic testing 0.430532 prenatal genetic test 0.402782 genetic mutations 0.44962 breast cancer 0.417779 Hereditary breast cancer 0.406679 people 0.398079 health care decisions 0.427407 genetic testing 0.952895 cancer risk 0.555583 hereditary cancer 0.711991 cancer 0.86681 information 0.408541	CLICK HERE
1896	National Cancer Institute	Html	es	Tratamiento del cáncer de páncreas (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento del cáncer de páncreas.	estadio lV 0.425648 pequeñas incisiones 0.367032 aguja fina 0.488715 siguientes procedimientos 0.412593 Estadio IA 0.426998 estadio iv 0.507764 siguientes aspectos 0.382876 Ecografía abdominal 0.386812 estadio ii 0.546166 células endocrinas 0.43128 causa ictericia 0.369929 estadios ia 0.357173 siguientes tipos 0.356896 Estadio IIA 0.42546 rayos x 0.367548 enlace drugs approved 0.5669 melanoma familiar atípico 0.436475 ondas sonoras 0.371814 cercanos.ampliar cáncer 0.946814 tumores neuroendocrinos 0.380539 National Cancer Institute 0.355543 estadio lB 0.430806 tejidos cercanos.ampliar cáncer 0.74829	endocrina múltiple tipo 0.4367 Instituto Nacional 0.397986 estadios iia 0.360412 PDQ Tratamiento 0.883614 presente sumario 0.428926 oculto detrás 0.371225 antecedentes familiares 0.366146 Colangiopancreatografía retrógrada 0.374947 Elabora hormonas 0.377934 estadio llA 0.424706 explorador tep 0.376314 Pancreatectomía distal 0.35778 Physician Data Query 0.499092 Pancreatic Cancer 0.442415 enzimas pancreáticas 0.350126 estadio iii 0.513007 Cirugía paliativa 0.414657 antígeno carcinoembrionario 0.380177 von hippel-lindau 0.376964 ovario hereditario 0.376013 linfáticos cercanos.ampliar cáncer 0.783386 siguientes pruebas 0.38409	CLICK HERE
1912	National Cancer Institute	Html	es	Tratamiento de la leucemia mieloide aguda y otras neoplasias mieloides malignas infantiles (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento del cáncer de la leucemia mieloide aguda y otras neoplasias mieloides malignas infantiles.	síndromes mielodisplásicos.Quimioterapia 0.302945 linfocítica aguda 0.307126 siguientes procedimientos 0.33161 siguientes aspectos 0.303162 Neurofibromatosis tipo 0.303799 células madre formadoras 0.308269 siguientes especialistas 0.302945 hueso compacto 0.308024 neoplasias mieloides 0.310246 célula madre mieloide 0.324347 Bultos indoloros 0.302618 líquido cefalorraquídeo 0.326401 leucemia mielomonocítica 0.41887 Instituto Nacional 0.305639 célula madre linfoide 0.318549 siguientes problemas 0.302781 leucemia mielógena 0.419565 neoplasias mielodisplásicas 0.302899 LMA recién 0.316713 cáncer regrese).El 0.307025 madre mieloides 0.328575 células madre mieloides 0.318746 leucemia promielocítica aguda 0.371662 células madre 0.977959 leucemia mielógena aguda 0.321693	leucemia aguda 0.310888 leucemia linfoblástica aguda 0.335277 síndromes mielodisplásicos 0.43219 enlace drugs approved 0.308769 Acute Myeloid Leukemia 0.309058 infantil recidivante 0.30755 Sudores nocturnos 0.302372 efectos tardíos 0.309904 médula ósea.Leucemia mielógena 0.31318 células cancerosas.El gemtuzumab 0.309349 punción espinal.Ampliar 0.30255 leucemia granulocítica aguda 0.320187 PDQ Tratamiento 0.305949 blastocitos mieloides 0.303489 tirosina cinasa 0.339619 sistema nervioso central 0.381371 leucemia mieloblástica aguda 0.320188 Physician Data Query 0.305829 enfermedades mieloides 0.315553 SMD)Algunos tratamientos 0.302284 revés.La prueba 0.301997 leucemia mieloide aguda 0.981978 célula madre 0.354129 siguientes sumarios 0.305018	CLICK HERE
1969	National Cancer Institute	Html	es	Tratamiento del sarcoma de tejido blando en adultos (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento del sarcoma de tejido blando en adultos.	estadio lV 0.482165 siguientes procedimientos 0.954883 estadio iv 0.615433 siguientes elementos 0.511302 Neurofibromatosis tipo 0.50222 von recklinghausen 0.491269 estadios ia 0.468147 vía oral 0.457153 estadio il 0.488391 rayos x 0.474452 único tratamiento 0.566108 estadio ib 0.532006 menor cantidad 0.562912 estadio ia 0.530637 carcinoma nevoide 0.493219 National Cancer Institute 0.451467 siguientes riesgos 0.443955 Instituto Nacional 0.590522	PDQ Tratamiento 0.505529 alta potencia 0.472015 estadio iia 0.534137 presente sección 0.449331 tumor haces estrechos 0.590695 Drugs Approved 0.457515 partes distantes 0.468081 Physician Data Query 0.588152 Soft Tissue Sarcoma 0.634121 radioterapia externa causa 0.549798 adultos causa efectos 0.535671 área enteras 0.486295 siguientes enlaces 0.454055 siguientes pruebas 0.644136 siguientes sumarios 0.574908 siguientes estadios 0.500903 siguientes trastornos 0.524918	CLICK HERE
2070	National Cancer Institute	Html	es	Inhibidores de la angiogénesis	Hoja informativa que describe el proceso de eliminación de suministro de sangre a los tumores. Incluye una lista de los cánceres en los que se está probando este enfoque.	vasos sanguíneos resultantes 0.32417 NCI de estudios 0.304711 llamadas metástasis 0.305878 posibles efectos 0.304824 Drug Administration 0.306756	células renales 0.307581 angiogénesis efectos 0.326284 Estados Unidos 0.315596 vasos sanguíneos 0.986577	CLICK HERE
15801	National Cancer Institute	Html	null	Recommendations of the Blue Ribbon Panel	Blue Ribbon Panel Report supporting materials include detailed reports from the BRP's seven working groups and a summary report on the public idea submission site.			CLICK HERE
16680	National Cancer Institute	Html	en	Cancer Moonshot℠ Implementation	Implementation teams are considering multiple ways to fund new programs as well as expansions of ongoing efforts to advance the goals of the Cancer Moonshot.	Cancer Moonshot-related research 0.688251 ongoing efforts 0.579887 funding opportunity announcements 0.69197 authorization 0.517804 oversight 0.515337 Cancer Moonshot portfolio 0.716496 academia 0.515431 Cancer Moonshot goals 0.684682 Century Cures Act 0.85793 expansions 0.51624 implementation teams 0.716347 email Partnerships_CancerMoonshot 0.582993 list 0.516345 Scientific Advisors 0.584259 important role 0.585193 longer-term scientific initiatives 0.700429 research opportunities 0.75591 multiple ways 0.591922 private sector 0.587499 Cancer Moonshot 0.987984 Cancer Moonshot initiatives 0.68956 concept proposals 0.656557 automatic email 0.583279 receipt 0.519207	NCI intramural staff 0.745934 cancer research community 0.682183 NCI extramural program 0.749793 Program Leadership Committee 0.655079 potential partners 0.586537 available FOAs 0.62206 NCI’s Board 0.674346 NIH institutes 0.582819 existing funds 0.59672 new research opportunities 0.683581 21st Century Cures 0.861565 scientific opportunities 0.594628 Blue Ribbon Panel 0.846596 BRP recommendation 0.740701 working groups 0.588634 new funding concepts 0.653803 BRP recommendations 0.654047 Public-private partnerships 0.590589 Cancer Moonshot implementation 0.678145 NCI advisory committees 0.753041 NCI’s Scientific 0.67691 report 0.517155 new programs 0.586358 funding mechanism 0.587953	CLICK HERE
16708	National Cancer Institute	Html	en	ALCHEMIST (The Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trials): Questions and Answers	ALCHEMIST represents three integrated, precision medicine trials that are designed to identify people with early-stage lung cancer who have tumors that harbor certain uncommon genetic changes and evaluate whether drug treatments targeted against those mol	certain genetic alterations 0.511031 ALK gene rearrangement 0.86792 specific genetic alterations 0.510493 lung cancer 0.965003 ALK genetic alterations 0.561732 component trials 0.510228 National Clinical Trials 0.497396 clinical trials 0.62346 early-stage lung cancer 0.707269 EGFR gene mutation 0.628828 best treatment approach 0.483241 lung cancers 0.649896 ALK Treatment component 0.564764 ECOG-ACRIN Cancer Research 0.536673 ALK rearrangement 0.515701 non-small cell lung 0.519586 Adjuvant Lung Cancer 0.554841 EGFR gene mutations 0.510846 uncommon genetic changes 0.484048 ALCHEMIST treatment trial 0.613717 new treatment approaches 0.481108 lung carcinoid tumors 0.539366 early-stage lung cancers 0.57159 appropriate ALCHEMIST treatment 0.663904	ALK gene 0.888431 precision medicine trials 0.560161 tumor tissue 0.58358 United States 0.513049 Dana-Farber Cancer Institute 0.495276 ALK alterations 0.531283 small cell lung 0.519071 National Cancer Institute 0.484824 ALCHEMIST study 0.594796 cancer risk characteristics 0.487226 EGFR Treatment component 0.512344 participants 0.568322 ALCHEMIST treatment trials 0.868218 genetic alterations 0.637424 complete surgical removal 0.527484 Cancer Research Group 0.536403 early-stage lung adenocarcinoma 0.54246 cell lung cancer 0.575738 Cancer Genomics 0.482098 FDA-approved Vysis ALK 0.52631 ALCHEMIST screening trial 0.716569 ALCHEMIST trials 0.680442 standard therapy 0.505511 Clinical Trials Agreement 0.491455	CLICK HERE